Zobrazeno 1 - 10 of 1 376 pro vyhledávání: '"Spotti M"'
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Prescription habits and drugs accessibility for the treatment of non-tuberculous mycobacteria infections in Italy: a multicentric survey from the IRENE study group.
Autor: Stroffolini G; Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Via Don Angelo Sempreboni 5, Negrar, Verona, Italy. giacomo.stroffolini@gmail.com., Lupia T; Unit of Infectious Diseases, Cardinal Massaia, 14100, Asti, Italy.; Department of Medical Sciences, Infectious Diseases, University of Turin, 10126, Turin, Italy., Gaviraghi A; Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Via Don Angelo Sempreboni 5, Negrar, Verona, Italy., Venuti F; Department of Medical Sciences, Infectious Diseases, University of Turin, 10126, Turin, Italy., Cinnirella G; Pharmacy Department, Asl Città di Torino, Turin, Italy., Gori A; Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy., Spotti M; Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy., Blasi F; Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy., Codecasa L; Regional TB Reference Centre, Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Calcagno A; Department of Medical Sciences, Infectious Diseases, University of Turin, 10126, Turin, Italy. andrea.calcagno@unito.it., Aliberti S; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy.; IRCCS Humanitas Research Hospital, Respiratory Unit, Via Manzoni 56, Rozzano, 20089, Milan, Italy.
Publikováno v: Infection [Infection] 2024 Sep 20. Date of Electronic Publication: 2024 Sep 20.
Zobrazit plný text záznamu
6
Akademický článek
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.
Autor: Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Harvard Chan School of Public Health, Harvard University, Boston, MA, USA., Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: dario.trapani@ieo.it., Zagami P; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Antonarelli G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Nicolò E; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA., Ribeiro JM; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Guidi L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Reduzzi C; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA., Spotti M; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Adamoli L; Clinical Trial Office, European Institute of Oncology, IRCCS, Milan, Italy., Cortès J; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain; IOB Madrid, Institute of Oncology, Hospital Beata María Ana, Madrid, Spain., Pistilli B; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Ueno N; University of Hawai'i Cancer Center, Honolulu, HI, USA., Layman RM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cristofanilli M; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA., Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Munzone E; Division of Medical Senology, European Institute of Oncology IRCCS, Milan, Italy., Criscitiello C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Woodward WA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Oct 28; Vol. 213, pp. 115097. Date of Electronic Publication: 2024 Oct 28.
Zobrazit plný text záznamu
7
Akademický článek
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Autor: Riudavets M; Medical Oncology Department, Gustave Roussy cancer campus, Villejuif, France., Auclin E; Medical Oncology Department, Hôpital Européen Georges Pompidou, AP-HP Centre, Université Paris Cité, Paris, France., Mosteiro M; Medical Oncology Department, Institut Català d'Oncologia - ICO Hospitalet, Barcelona, Spain., Dempsey N; Medical Oncology Department, Jackson Memorial Hospital, Miami, FL., Majem M; Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Prelaj A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milan, Milano, Italy., López-Castro R; Medical Oncology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Bosch-Barrera J; Medical Oncology Department, Catalan Institute of Oncology, Hospital Universitari Josep Trueta, Girona, Spain., Pilotto S; Medical Oncology Department, University and Hospital Trust of Verona, Verona, Italy., Escalera E; Medical Oncology Department, Hospital Clínico de Salamanca, Salamanca, Spain., Tagliamento M; Medical Oncology Department, Gustave Roussy cancer campus, Villejuif, France; Internal Medicine and Medical Specialties Department, University of Genova, Genova, Italy., Mosquera J; Medical Oncology Department, Hospital Universitario A Coruña, A Coruña, Spain., Zalcman G; Université Paris Cité, Thoracic Oncology Department, CIC Inserm 1425, Hôpital Bichat-Claude Bernard, Paris, France., Aboubakar Nana F; Division of Pneumology, Cliniques universitaires Saint-Luc, Bruxelles, Belgium., Ponce S; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain., Albarrán-Artahona V; Medical Oncology Department, Department of Medicine, Hospital Clinic, Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, University of Barcelona, Barcelona, Spain., Dal Maso A; Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy., Spotti M; Medical Oncology Department, Hospital Alemán, Buenos Aires, Argentina., Mielgo X; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Mussat E; Medical Oncology Department, Hôpital Européen Georges Pompidou, AP-HP Centre, Université Paris Cité, Paris, France., Reyes R; Medical Oncology Department, Department of Medicine, Hospital Clinic, Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, University of Barcelona, Barcelona, Spain., Benítez JC; Medical Oncology Department, Gustave Roussy cancer campus, Villejuif, France; Medical Oncology Department, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain., Lupinacci L; Medical Oncology Department, Hospital Italiano, Buenos Aires, Argentina., Duchemann B; Medical Oncology Department, Hôpital Avicenne, Bobigny, France., De Giglio A; Medical Oncology Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Blaquier JB; Medical Oncology Department, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina., Audigier-Valette C; Medical Oncology Department, Centre Hospitalier Toulon Sainte-Mousse, Toulon, France., Scheffler M; Internal Medicine I Department, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Nadal E; Medical Oncology Department, Institut Català d'Oncologia - ICO Hospitalet, Barcelona, Spain., Lopes G; Medical Oncology Department, Jackson Memorial Hospital, Miami, FL., Signorelli D; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milan, Milano, Italy; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Garcia-Campelo R; Medical Oncology Department, Hospital Universitario A Coruña, A Coruña, Spain., Menis J; Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Padova, Italy., Bluthgen V; Medical Oncology Department, Hospital Alemán, Buenos Aires, Argentina., Campayo M; Medical Oncology Department, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain., Recondo G; Medical Oncology Department, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina., Besse B; Medical Oncology Department, Gustave Roussy cancer campus, Villejuif, France., Mezquita L; Medical Oncology Department, Department of Medicine, Hospital Clinic, Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: lmezquita@clinic.cat., Planchard D; Medical Oncology Department, Gustave Roussy cancer campus, Villejuif, France.
Publikováno v: Clinical lung cancer [Clin Lung Cancer] 2024 May; Vol. 25 (3), pp. 233-243.e8. Date of Electronic Publication: 2023 Nov 22.
Zobrazit plný text záznamu
8
CoMMiTTEd - Covid, Migrant:innen und Minderheiten in der Lehrkräfteausbildung: Ein Fake News-Observatorium zur Förderung des kritischen Denkens und der digitalen Kompetenz in Krisenzeiten. E-Handbuch für Lehrkräfte und Lehrkräfte-Ausbilder:innen
Autor: Araújo e Sá, M. H., Gerwers, Franziska, Gintsburg, S., Spotti, M.
Dieses pädagogische e-Handbuch deckt zwar nicht alle Themen im Zusammenhang mit der Entwicklung von Lehrkompetenzen für den Umgang mit FN ab, wurde aber als praktische Ressource für Lehrkräfte (im Studium, im Vorbereitungsdienst oder in Fortbildu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aaebb0653041d3b2051db29a8ae40e9
Zobrazit plný text záznamu
9
CoMMiTTEd - COVID, Migrantes y Minorías en la formación docente: Observatorio de noticias falsas para promover el pensamiento crítico y la alfabetización digital en tiempos de crisis. Manual digital para profesores y formadores de futuros docentes
Autor: Araújo e Sá, M. H., Gerwers, Franziska, Gintsburg, S., Spotti, M.
Este manual electrónico, pese a que no incluye todas las cuestiones que forman parte de la educación contra la desinformación, ofrece un recurso práctico para los actuales o futuros profesores acerca de cómo pueden integrar el tema de las notici
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cef71cb2fc066790c4952810f0e9bf2
Zobrazit plný text záznamu
10
CoMMiTTEd - Covid, Migrants and Minorities in Teacher Education: A Fake News Observatory to Promote Critical Thinking and Digital Literacy in Times of Crisis. E-handbook for teachers and teacher educators
Autor: Araújo e Sá, M. H., Gerwers, F., Gintsburg, S., Spotti, M.
This pedagogical e-handbook, while not covering all the issues related to the development of teacher competences to cope with FN, was designed as a hands-on resource for teachers (pre-service or in-service) and teacher educators about possible ways o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1454f8e32323b5bbf8885fc47dca91a5
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje